T2 Biosystems Inc (OQ:TTOO)

Business Focus: Advanced Medical Equipment & Technology

Sep 16, 2020 08:00 am ET
T2 Biosystems to Participate in Sepsis Alliance Summit
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it is participating in the virtual, inaugural Sepsis Alliance Summit taking place September 16-17, 2020, through a sponsorship and...
Sep 04, 2020 07:00 am ET
T2 Biosystems Announces CMS Approval of a New Technology Add-On Payment for the T2Bacteria® Panel for a Second Year
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) continued the New Technology Add-on Payment (NTAP) for the Company’s...
Aug 31, 2020 04:05 pm ET
T2 Biosystems Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its COVID-19 molecular diagnostic...
Aug 11, 2020 04:05 pm ET
T2 Biosystems Announces Second Quarter 2020 Financial Results
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the second quarter ended June 30, 2020. Recent Highlights Achieved second quarter total revenue of $2.6 million...
Aug 05, 2020 07:30 am ET
T2 Biosystems Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that its Board of Directors has decided it will not seek authority from the stockholders at the 2020 Annual Meeting (“Annual Meeting”)...
Aug 04, 2020 09:31 am ET
Thinking about trading options or stock in Varian Medical Systems, Sorrento Therapeutics, T2 Biosystems, Ford Motor, or American Airlines?
NEW YORK, Aug. 4, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VAR, SRNE, TTOO, F, and AAL....
Jul 30, 2020 04:05 pm ET
T2 Biosystems to Participate in the Canaccord Genuity Annual Growth Conference
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming virtual Canaccord Genuity Annual Growth Conference. Management is scheduled to...
Jul 28, 2020 04:05 pm ET
T2 Biosystems to Report Second Quarter 2020 Financial Results on August 11, 2020
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the second quarter of 2020 after market close on Tuesday, August 11, 2020. Company management...
Jul 16, 2020 09:31 am ET
Thinking about buying stock in Ashford Hospitality Trust, Boxlight Corp, T2 Biosystems, Southwest Airlines, or Heat Biologics?
NEW YORK, July 16, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AHT, BOXL, TTOO, LUV, and HTBX....
Jul 01, 2020 09:31 am ET
Thinking about buying stock in T2 Biosystems, Ameresco Inc, Xeris Pharmaceuticals, Blink Charging, or Kitov Pharma?
NEW YORK, July 1, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TTOO, AMRC, XERS, BLNK, and KTOV....
Jun 30, 2020 04:06 pm ET
T2 Biosystems Announces U.S. Launch of COVID-19 Diagnostic Test
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the completion of validation of its COVID-19 molecular diagnostic test, the T2SARS-CoV-2 Panel. The test was developed by T2 Biosystems...
Jun 30, 2020 04:04 pm ET
T2 Biosystems Announces Preliminary Second Quarter 2020 Financial Results
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited preliminary financial result estimates for the quarter ended June 30, 2020. In addition, the Company announced the U.S. launch...
Jun 26, 2020 08:00 am ET
T2 Biosystems Reports Granting of Inducement Award
T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to four new employees. The awards were made on May 5, 2020 and June 2, 2020 under T2 Biosystems’...
Jun 17, 2020 07:30 am ET
T2 Biosystems Regains Compliance with NASDAQ Listing Requirements
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that on June 16, 2020 it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (“Nasdaq”)...
Jun 15, 2020 04:06 pm ET
T2 Biosystems Announces Changes to Board of Directors
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced three new Board of Director appointments. The three new directors will add significant clinical and commercialization experience and...
Jun 12, 2020 09:31 am ET
Thinking about buying stock in Valaris PLC, T2 Biosystems, Seanergy Maritime, Global Eagle Entertainment, or Penn National Gaming?
NEW YORK, June 12, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for VAL, TTOO, SHIP, ENT, and PENN....
Jun 10, 2020 09:31 am ET
Thinking about buying stock in Lakeland Industries, Capricor Therapeutics, T2 Biosystems, Callon Petroleum, or TOP Ships?
NEW YORK, June 10, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LAKE, CAPR, TTOO, CPE, and TOPS....
Jun 03, 2020 09:31 am ET
Thinking about buying stock in Digital Turbine, Mattel, T2 Biosystems, Altimmune, or Moneygram International?
NEW YORK, June 3, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for APPS, MAT, TTOO, ALT, and MGI....
May 19, 2020 10:30 am ET
Thinking about buying stock in Oragenics Inc, T2 Biosystems, Norwegian Cruise Lines, Sea Limited, or cbdMD Inc?
NEW YORK, May 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OGEN, TTOO, NCLH, SE, and YCBD....
May 19, 2020 08:30 am ET
T2 Biosystems’ Bacteria Panel Wins “Best New Technology Solution - Diagnostics" Award in MedTech Breakthrough Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced it won the “Best New Technology Solution - Diagnostics" award for its T2Bacteria® Panel solution in the fourth annual MedTech...
May 05, 2020 04:05 pm ET
T2 Biosystems Announces First Quarter 2020 Financial Results
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the first quarter ended March 31, 2020. Recent Highlights Achieved first quarter total revenue of $2.5 million...
Apr 21, 2020 04:22 pm ET
T2 Biosystems to Report First Quarter 2020 Financial Results on May 5, 2020
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the first quarter of 2020 after market close on Tuesday, May 5, 2020. Company management will...
Apr 15, 2020 05:06 pm ET
T2 Biosystems Reports Granting of Inducement Award
T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens, announced today that it issued inducement awards to four new employees. The awards were made on March 18, 2020 and April 14, 2020 under T2 Biosystems’...
Mar 27, 2020 09:31 am ET
Thinking about buying stock in Aytu Bioscience, GameStop, Translate Bio, Tilray, or T2 Biosystems?
NEW YORK, March 27, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AYTU, GME, TBIO, TLRY, and TTOO....
Mar 24, 2020 04:31 pm ET
T2 Biosystems Announces Worldwide Licensing Agreement of COVID-19, Novel Coronavirus Assay from Hackensack Meridian Health’s Center for Discovery and Innovation
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it has entered into a worldwide licensing agreement for a rapid COVID-19, novel coronavirus test developed by the Center of...
Mar 24, 2020 04:30 pm ET
T2 Biosystems Announces Preliminary First Quarter 2020 Financial Results
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced unaudited, preliminary financial result estimates for the quarter ended March 31, 2020, and suspended full year 2020 financial and...
Mar 19, 2020 08:00 am ET
T2 Biosystems Receives Multiyear Innovative Technology Contract from Vizient, Inc.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that it was awarded an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement...
Feb 24, 2020 04:05 pm ET
T2 Biosystems Announces Fourth Quarter and Full Year 2019 Financial Results
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Recent Business and Financial...
Feb 19, 2020 04:05 pm ET
T2 Biosystems to Participate in the SVB Leerink Global Healthcare Conference
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that the Company plans to participate in the upcoming SVB Leerink Global Healthcare Conference in New York, New York. Management is...
Feb 12, 2020 04:05 pm ET
T2 Biosystems to Report Fourth Quarter and Full Year 2019 Financial Results on February 24, 2020
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today that it will report financial results for the fourth quarter and full year 2019 after market close on Monday, February 24, 2020. Company...
Feb 04, 2020 09:30 am ET
T2 Biosystems Announces Participation at Clinical Conferences in February
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the Company’s participation in two conferences in February: Society of Critical Care Medicine’s (SCCM) 48th Critical Care Congress, and...
Jan 17, 2020 04:15 pm ET
T2 Biosystems Reports Granting of Inducement Award
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement award to John Sperzel, the...
Jan 13, 2020 07:30 am ET
T2 Biosystems Promotes Tony Pare to Chief Commercial Officer
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that its Chief Executive Officer (CEO), John Sperzel, has promoted Tony Pare to the newly...
Jan 09, 2020 04:30 pm ET
T2 Biosystems Announces Preliminary Fourth Quarter 2019 Financial Results
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced preliminary revenue and business results for the three months ended December 31, 2019....
Jan 09, 2020 04:15 pm ET
T2 Biosystems Appoints Industry Veteran John Sperzel as Chief Executive Officer
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that its Board of Directors has appointed diagnostics industry veteran John Sperzel as...
Dec 13, 2019 04:15 pm ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on December 4, 2019 it issued inducement awards to two new...
Nov 20, 2019 07:30 am ET
T2 Biosystems Announces Granting of CE-Mark for T2Resistance™ Panel
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, and CARB-X, a global non-profit partnership dedicated to accelerating R&D...
Nov 15, 2019 07:30 am ET
T2 Biosystems to Present at the 13th Annual Canaccord Genuity Medical Technology & Diagnostics Forum
T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company,”“T2,” or “T2 Biosystems”), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough,...
Nov 12, 2019 07:30 am ET
T2 Biosystems Reports Third Quarter 2019 Financial Highlights and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company,”“T2,” or “T2 Biosystems”), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights...
Nov 08, 2019 04:15 pm ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on November 5, 2019 it issued inducement awards to four new...
Nov 07, 2019 07:30 am ET
T2 Biosystems to Share Early Data at the World Anti-Microbial Resistance Congress (November 7-8, 2019)
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will be highlighting its portfolio and pipeline of products in a keynote presentation...
Oct 31, 2019 04:15 pm ET
T2 Biosystems Announces 2019 Third Quarter Financial and Operational Results Release and Conference Call Date
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019 third quarter financial and operational results before the market...
Oct 11, 2019 07:30 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on October 3, 2019 it issued inducement awards to two new...
Oct 02, 2019 07:30 am ET
T2 Biosystems to Showcase Latest Innovations at IDWeek 2019
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will showcase its latest rapid diagnostics for the detection of sepsis-causing...
Sep 30, 2019 07:30 am ET
T2 Biosystems’ T2Resistance™ Panel is Now Available as a Research Use Only (RUO) Test in the U.S.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that its T2ResistanceTM Panel, which received Breakthrough Device Designation from the Food and...
Sep 26, 2019 04:15 pm ET
T2 Biosystems to Present at the 2019 Cantor Global Healthcare Conference
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, chairman and chief executive officer, and John Sprague, chief financial...
Sep 25, 2019 07:30 am ET
T2 Biosystems Enters into Distribution Agreement to Expand its Innovative Rapid Diagnostic Technologies to Puerto Rico and the U.S. Virgin Islands
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it entered into an exclusive distribution agreement that allows the Company to introduce...
Sep 24, 2019 07:00 am ET
T2 Biosystems’ T2Resistance™ Panel is First Diagnostic to Graduate from CARB-X Portfolio
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, and CARB-X, a global non-profit partnership dedicated to accelerating early...
Sep 19, 2019 07:30 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on September 9, 2019 it issued inducement awards to four new...
Sep 11, 2019 09:31 am ET
Thinking about buying stock in Aurora Cannabis, Bank of America, Francesca's, T2 Biosystems, or Yuma Energy?
NEW YORK, Sept. 11, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ACB, BAC, FRAN, TTOO, and YUMA....
Sep 11, 2019 09:30 am ET
T2 Biosystems Receives Funding from BARDA to Advance Technology for Diagnosis and Treatment of Bloodstream Infections
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it has been awarded a milestone-based contract of...
Sep 10, 2019 04:21 pm ET
T2 Biosystems to Host Conference Call to Discuss Awarding of Multi-Million Dollar BARDA Contract
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today it will host a conference call and webcast to discuss the up to $69 million milestone-based...
Sep 10, 2019 04:14 pm ET
T2 Biosystems Announces Restructuring of CRG Term Loan Agreement
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it has restructured its Term Loan Agreement with CRG Servicing LLC (“CRG”).  The key...
Sep 10, 2019 04:05 pm ET
T2 Biosystems Awarded Breakthrough Technology Contract with Premier Inc.
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that Premier Inc., a healthcare improvement company, as part of their Technology Breakthroughs...
Aug 29, 2019 07:30 am ET
T2 Biosystems to Present at the Janney Healthcare Conference 2019
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, chairman and chief executive...
Aug 16, 2019 07:30 am ET
T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it entered into an exclusive distribution agreement that allows the Company to introduce...
Aug 14, 2019 04:30 pm ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on August 1, 2019 it issued inducement awards to five new...
Aug 06, 2019 09:31 am ET
Thinking about buying stock in Activision Blizzard, Bank of America, Walt Disney, General Electric, or T2 Biosystems?
NEW YORK, Aug. 6, 2019 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ATVI, BAC, DIS, GE, and TTOO....
Aug 06, 2019 07:30 am ET
T2Bacteria Panel is the First and Only In-Vitro Diagnostic Test to Receive Approval for a New Technology Add-on Payment by CMS
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that the United States Centers for Medicare & Medicaid...
Jul 30, 2019 04:01 pm ET
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights and financial results for the second...
Jul 30, 2019 07:30 am ET
T2 Biosystems to Present at the Canaccord Genuity Growth Conference
T2 Biosystems, Inc. (the “Company”) (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John Sprague, Chief Financial Officer, and...
Jul 26, 2019 07:30 am ET
T2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it entered into exclusive distribution agreements with five new distribution partners in...
Jul 24, 2019 07:30 am ET
T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019 second quarter financial and operational...
Jul 03, 2019 07:30 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on July 1, 2019 it issued inducement awards to three new...
Jun 28, 2019 07:30 am ET
T2 Biosystems Named One of the Fastest-Growing Companies in Massachusetts
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, ranked #22 among the top 50 fastest growing public companies in Massachusetts by the Boston Business Journal....
Jun 20, 2019 07:30 am ET
T2 Biosystems Introduces New Clinical Data and Updates Regarding Expanding Capabilities of its Rapid Diagnostic Technology at ASM Microbe 2019
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, will share multiple updates regarding the clinical utility of its expanding portfolio of...
Jun 17, 2019 07:30 am ET
T2 Biosystems Highlights Current and Future Opportunities for its Breakthrough Rapid Diagnostic Technology for Biothreat Pathogen Detection
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that the Company will present new data regarding the potential of its...
Jun 12, 2019 07:30 am ET
T2 Biosystems to Highlight its Products and Technology at Upcoming Medical Meetings
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it will highlight its rapid molecular diagnostic products and technology, including the...
Jun 10, 2019 07:30 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on June 4, 2019 it issued inducement awards to two new...
Jun 06, 2019 07:30 am ET
New Studies Highlight Potential for T2Bacteria and T2Candida Panels to Improve Outcomes and be Cost-Effective for Sepsis Patients in the Medical Intensive Care Unit and Emergency Department
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today the publication of two independent, peer-reviewed studies highlighting the potential of the...
May 24, 2019 07:30 am ET
T2 Biosystems to Participate in Singular Research Spring Select Web Call
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, chief executive officer, and John Sprague, chief financial officer, are...
May 23, 2019 11:08 am ET
Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, highlighted the latest clinical data and customer case studies for the T2Bacteria® and...
May 14, 2019 07:00 am ET
Publication in Annals of Internal Medicine® Reveals T2Bacteria® Panel as the First Direct-from-Blood, Non-Culture Test that Rapidly Diagnoses Bacterial Bloodstream Infections
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that results from a pivotal trial were published online in the Annals of Internal Medicine®...
May 13, 2019 04:30 pm ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on May 8, 2019 it issued inducement awards to three new...
May 08, 2019 02:45 pm ET
T2 Biosystems to Showcase Breakthrough Rapid Diagnostics During 22nd Annual MAD-ID Meeting in Orlando, Florida
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that the Company will highlight its products at the 22nd Annual MAD-ID...
May 02, 2019 04:01 pm ET
T2 Biosystems Reports First Quarter 2019 Financial Results and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights and financial results for the first...
Apr 18, 2019 04:30 pm ET
T2 Biosystems Announces 2019 First Quarter Financial and Operational Results Release and Conference Call Date
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2019 first quarter financial and operational results...
Apr 16, 2019 07:30 am ET
New Research Coverage Highlights Franklin Resources, Corporate Office Properties Trust, Guidewire Software, Bemis, T2 Biosystems, and Zosano Pharma — Consolidated Revenues, Company Growth, and Expecta
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Franklin Resources, Inc. (NYSE:BEN), Corporate Office Properties Trust...
Apr 09, 2019 08:00 am ET
T2 Biosystems and Clinicians to Share Clinical Data in Integrated Symposium and Poster Presentations at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID)
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that the Company will host an integrated symposium highlighting key clinical...
Apr 08, 2019 04:30 pm ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on March 15, 2019 it issued inducement awards to seven new...
Apr 03, 2019 07:30 am ET
T2 Biosystems to Present at the 18th Annual Needham Healthcare Conference
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John Sprague, chief financial officer, is scheduled to...
Mar 07, 2019 04:01 pm ET
T2 Biosystems Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights and financial results for the fourth...
Feb 27, 2019 04:01 pm ET
FDA Grants T2 Biosystems Breakthrough Device Designation for the T2Resistance™ Panel; Expected Availability through CE Mark in 2019
The FDA has granted T2 Biosystems, Inc. (NASDAQ:TTOO) “Breakthrough Device” designation for the T2Resistance Panel, a diagnostic panel that can detect 13 resistance genes from both gram-positive and gram-negative pathogens from a single patient...
Feb 26, 2019 07:30 am ET
Detailed Research: Economic Perspectives on Altice, Just Energy Group, Ultra Petroleum, RadNet, T2 Biosystems, and Calumet Specialty Products Partners — What Drives Growth in Today's Competitive Lands
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Altice USA, Inc. (NYSE:ATUS), Just Energy Group, Inc. (NYSE:JE), Ultra...
Feb 21, 2019 07:30 am ET
T2 Biosystems to Present at the 8th Annual SVB Leerink Global Healthcare Conference
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is...
Feb 20, 2019 04:30 pm ET
T2 Biosystems Announces 2018 Fourth Quarter and Full Year Financial and Operational Results Release and Conference Call Date
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it will release its 2018 fourth quarter and full year...
Feb 20, 2019 12:00 pm ET
Fast Company Names T2Biosystems One of the World’s Most Innovative Companies – For Battling Sepsis in Hours not Days
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, was recognized today by Fast Company among the top 10 of the world’s most innovative companies in the biotech...
Feb 07, 2019 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on February 1, 2019 it issued inducement awards to four new...
Jan 23, 2019 07:00 am ET
T2 Biosystems to Participate in Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that Tom Lowery, Ph.D., chief scientific officer, will present to the Presidential Advisory...
Jan 08, 2019 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on January 2, 2019 it issued inducement awards to six new...
Dec 07, 2018 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on December 4, 2018 it issued inducement awards to six new...
Nov 29, 2018 07:45 am ET
New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors — Factors of Influence, Major Initiatives and Susta
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Upland Software, Inc. (NASDAQ:UPLD), VICI Properties Inc. (NYSE:VICI),...
Nov 08, 2018 07:00 am ET
T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is...
Nov 07, 2018 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on November 1, 2018 it issued inducement awards to six new...
Nov 01, 2018 04:01 pm ET
T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today the operating highlights and financial results for the third...
Oct 22, 2018 07:20 am ET
Consolidated Research: 2018 Summary Expectations for Vuzix, BCE, Tetraphase Pharmaceuticals, T2 Biosystems, TPG Specialty Lending, and Jianpu Technology — Fundamental Analysis, Key Performance Indicat
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vuzix Corporation (NASDAQ:VUZI), BCE, Inc. (NYSE:BCE), Tetraphase...
Oct 18, 2018 07:00 am ET
T2 Biosystems Announces 2018 Third Quarter Financial and Operational Results Release and Conference Call Date
T2 Biosystems, Inc. (Nasdaq: TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that it will release its 2018 third quarter financial and...
Oct 05, 2018 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on October 2, 2018 it issued inducement awards to four new...
Oct 03, 2018 09:14 am ET
Antimicrobials Working Group Highlights Member Company Participation at IDWeek 2018
WASHINGTON, Oct. 3, 2018 /PRNewswire/ -- The Antimicrobials Working Group (AWG), a coalition of companies with the mission to combat drug resistant infections and spur life-saving innovations, announced today that 16 of its member companies will present data from their clinical and research programs at IDWeek 2018 to be held October 3-7 in San Francisco. AWG members are presenting a total of 40 poster presentations, four oral abstract presentations and four features within the symposium entitled "Exploring the Antibiotic Pipeline 2018."...
Oct 03, 2018 07:00 am ET
T2 Biosystems Announces Customer Presentations at October Conferences
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced upcoming scientific presentations that will be made by users of...
Sep 26, 2018 07:00 am ET
New Data Suggests T2 Biosystems’ T2Lyme™ Panel is More Accurate than Other Diagnostics for Identifying Borrelia Infections for Patients Suspected of Having Early Lyme Disease
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today new data suggesting the T2Lyme Panel™ is more accurate than other...
Sep 10, 2018 07:00 am ET
T2 Biosystems to Participate in Two Upcoming Investor Conferences
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive...
Sep 07, 2018 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on September 5, 2018 it issued inducement awards...
Aug 06, 2018 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on August 1, 2018 it issued inducement awards to...
Aug 02, 2018 04:01 pm ET
T2 Biosystems Reports Second Quarter 2018 Financial Results and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today operating highlights and financial results for the...
Jul 24, 2018 07:00 am ET
T2 Biosystems to Participate in Two Upcoming Conferences
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive...
Jul 20, 2018 07:00 am ET
T2 Biosystems Announces 2018 Second Quarter Financial and Operational Results Release and Conference Call Date
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that it will release its 2018 second quarter financial...
Jul 09, 2018 04:15 pm ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on July 2, 2018 it issued inducement awards to...
Jun 25, 2018 07:00 am ET
T2 Biosystems Added to the Russell 3000® Index
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today that it has been added to the broad-market Russell 3000® Index. The addition occurred...
Jun 13, 2018 07:00 am ET
Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announced today late-breaker posters and data presented at the American Society for Microbiology...
Jun 06, 2018 10:08 am ET
Antimicrobials Working Group Highlights Member Company Participation at ASM Microbe 2018
WASHINGTON, June 6, 2018 /PRNewswire/ -- The Antimicrobials Working Group (AWG) today announced that 13 of its member companies will present data from their clinical and research programs at the American Society for Microbiology's ASM Microbe 2018 meeting to be held June 7-11 in Atlanta, GA....
Jun 06, 2018 07:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on June 4, 2018 it issued inducement awards to...
Jun 05, 2018 07:00 am ET
T2 Biosystems Announces Closing of Public Offering of Common Stock
T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the closing of its underwritten public offering of 7,015,000 shares of common stock, including 915,000 shares of common stock pursuant to the underwriters’ exercise in full of their option to...
Jun 01, 2018 07:00 am ET
T2 Biosystems to Present at the Jefferies 2018 Global Healthcare Conference
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare, announced today that John McDonough, president and chief executive officer, is...
May 31, 2018 07:00 am ET
T2 Biosystems Announces Pricing of Public Offering of Common Stock
T2 Biosystems, Inc. (NASDAQ:TTOO) today announced the pricing of an underwritten registered public offering of 6,100,000 shares of common stock at a public offering price of $7.50 per share, before underwriting discounts, for gross proceeds of...
May 29, 2018 04:14 pm ET
T2 Biosystems Announces Proposed Public Offering of Common Stock
T2 Biosystems, Inc. (Nasdaq:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare, today announced that it is commencing an underwritten registered public...
May 29, 2018 07:00 am ET
T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative diagnostic products for critical unmet needs in healthcare, today announced that it has received market clearance from the U.S. Food and...
May 08, 2018 04:01 pm ET
T2 Biosystems Reports First Quarter 2018 Financial Results and Provides Corporate Update
T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today operating highlights and financial results for the first...
May 03, 2018 08:00 am ET
T2 Biosystems Reports Granting of Inducement Awards
T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on May 1, 2018 it issued inducement awards to four...
Apr 30, 2018 08:00 am ET
T2 Biosystems Announces 2018 First Quarter Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., April 30, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that it will release its...
Apr 20, 2018 10:17 am ET
Antimicrobials Working Group Highlights Member Company Participation at the 28th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
WASHINGTON, April 20, 2018 /PRNewswire/ -- The Antimicrobials Working Group (AWG) today announced that thirteen of its member companies will present data from their clinical and research programs at the annual meeting of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2018) to be held April 21 - 24 in Madrid, Spain. ...
Apr 04, 2018 04:05 pm ET
T2 Biosystems Reports Granting of Inducement Awards
LEXINGTON, Mass., April 04, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that on April 2, 2018...
Mar 28, 2018 10:46 am ET
Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics
U.S. and EU studies demonstrate that T2Dx diagnostics enable getting patients on the right therapy faster, improving outcomes, enhancing stewardship, and reducing the cost of care
Mar 28, 2018 08:30 am ET
Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics
U.S. and EU studies demonstrate that T2Dx diagnostics enable getting patients on the right therapy faster, improving outcomes, enhancing stewardship, and reducing the cost of care
Mar 19, 2018 04:05 pm ET
T2 Biosystems to Present at the 17th Annual Needham Healthcare Conference
LEXINGTON, Mass., March 19, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that John McDonough, president and...
Mar 07, 2018 08:00 am ET
T2 Biosystems Reports Granting of Inducement Award
LEXINGTON, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, announced today that it issued an inducement...
Mar 06, 2018 04:00 pm ET
T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update
Quarterly Product Revenue Up 125% Year-Over-Year and 76% Over the Prior Quarter
Mar 06, 2018 03:17 pm ET
T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria
New tests aim to expand T2Dx Instrument product line by detecting 20 additional bacterial species and resistance targets that could empower doctors to rapidly treat more patients with targeted therapy
Mar 06, 2018 07:00 am ET
T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria
T2 Biosystems Awarded Up To $2 Million by CARB-X to Support Development of New Tests on the T2Dx Instrument for Drug-Resistant Bacteria
Feb 20, 2018 08:00 am ET
T2 Biosystems Announces 2017 Fourth Quarter and Full-Year Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., Feb. 20, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that it will release its...
Feb 09, 2018 08:34 am ET
Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing
Studies demonstrate T2Candida identifies infections missed by blood culture and the opportunity for faster targeted therapy
Feb 06, 2018 08:00 am ET
T2 Biosystems to Present at the 7th Annual Leerink Partners Global Healthcare Conference
LEXINGTON, Mass., Feb. 06, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that John McDonough, president and chief executive officer...
Feb 05, 2018 04:30 pm ET
T2 Biosystems Announces CFO Transition
LEXINGTON, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the development of innovative medical diagnostic products for critical unmet needs in healthcare, today announced that John Sprague has been named chief financial...
Jan 04, 2018 04:05 pm ET
T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel
FDA Clearance of T2Bacteria® Panel remains on track for first quarter 2018
Nov 27, 2017 08:00 am ET
T2 Biosystems to Attend the Global Mizuho Investor Conference
LEXINGTON, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, today announced that John McDonough, president and chief executive officer, and...
Nov 20, 2017 09:26 am ET
T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017
Results Show Detection of Clinically Important Infections Missed by Blood Culture
Nov 09, 2017 08:00 am ET
T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017
LEXINGTON, Mass., Nov. 09, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced a workshop presentation on the T2Sepsis Solution™ during the Association for...
Nov 02, 2017 04:05 pm ET
T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update
Submitted 510(k) Application to the FDA Requesting Market Clearance for T2Bacteria PanelYear over Year Quarterly Product Revenue Growth of 27.4%...
Nov 02, 2017 04:05 pm ET
T2 Biosystems Reports Third Quarter 2017 Financial Results and Provides Company Update
Submitted 510(k) Application to the FDA Requesting Market Clearance for T2Bacteria PanelYear over Year Quarterly Product Revenue Growth of 27.4%
Sep 21, 2017 08:00 am ET
T2 Biosystems Announces Presentations at IDWeek 2017
LEXINGTON, Mass., Sept. 21, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced a panel presentation and six poster presentations during the IDWeek 2017 Conference in San Diego, CA, held October 4-8. The panel presentation will be focused on the positive impact of the T2Candida Panel, early experiences with the T2Bacteria Research Use Only (RUO) Panel and how the development of a diagnostic panel to detect Gram-negative bacterial species and antibiotic resistance should ...
Sep 18, 2017 08:00 am ET
T2 Biosystems to Present at the Cantor Fitzgerald Global Healthcare Conference
LEXINGTON, Mass., Sept. 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that John McDonough, president and chief executive officer, and Darlene Deptula-Hicks, SVP and chief financial officer, are scheduled to attend and present at the Cantor Fitzgerald Global Healthcare Conference. The conference is being held September 25-27, 2017 at the InterContinental New York Barclay Hotel in New York City....
Sep 11, 2017 08:00 am ET
T2 Biosystems Submits 510(k) Application to the FDA for Review of T2Bacteria Panel
LEXINGTON, Mass., Sept. 11, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, today announced that it has filed a 510(k) premarket submission for the T2Bacteria Panel with the U.S. Food and Drug Administration (FDA). The T2Bacteria Panel is designed to run on the FDA-cleared T2Dx Instrument. The T2Bacteria Panel, once FDA cleared, combined with the commercially available T2Candida Panel is designed to be the first comprehensive rapid diagnostic solution on the market that identifies p...
Sep 06, 2017 12:05 pm ET
Antimicrobials Working Group Member Companies Announce Partnership and Exclusive Pricing Program
WASHINGTON, Sept. 6, 2017 /PRNewswire/ -- The Antimicrobials Working Group (AWG) is pleased to announce that two of its member companies, T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, and Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, have entered into an exclusive partnership for commercial placement of T2Dx Instruments to support CD101 drug trials. The program is designed to accelerate enrollment in Cidara's CD101 trials targ...
Sep 06, 2017 07:05 am ET
T2 Biosystems and Cidara Therapeutics Announce Partnership for Commercial Placement of T2Dx Instruments to Support CD101 Drug Trials
LEXINGTON, Mass. and SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, and Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced an exclusive pricing program for the commercial placement of T2Dx Instruments. The preferred pricing structure will be exclusive to Cidara’s clinical trial sites. The program is designed to accelerate enrollment in clinical trials evaluating Cidara’s n...
Sep 06, 2017 07:00 am ET
T2 Biosystems Announces Collaboration with CDC to Detect Emerging Superbug Candida auris
CDC to Utilize T2Dx Instrument for Testing of Patient Samples and Monitoring Hospital Environments...
Aug 15, 2017 11:18 am ET
T2 Biosystems and Aridis Pharmaceuticals, Inc. Join Antimicrobials Working Group
WASHINGTON, Aug. 15, 2017 /PRNewswire/ -- The Antimicrobials Working Group (AWG) announced today the addition of two new members to their group of 12 companies with the mission to combat drug resistant infections and spur life-saving innovations. T2 Biosystems, Inc. (NASDAQ:TTOO), is an emerging leader in the development of innovative diagnostic products to improve patient health, and is AWG's first diagnostic member company. Aridis Pharmaceuticals, Inc. is a biopharmaceutical company applying proprietary technologies to produce novel immunotherapeutics for infectious diseases. ...
Aug 03, 2017 04:05 pm ET
T2 Biosystems Reports Second Quarter 2017 Financial Results; Provides Company Update
LEXINGTON, Mass., Aug. 03, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced today operating highlights and financial results for the second quarter ended June 30, 2017.  ...
Jul 27, 2017 08:58 am ET
T2 Biosystems Joins Antimicrobials Working Group as First Diagnostic Member
LEXINGTON, Mass., July 27, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced today that it will join the Antimicrobials Working Group (AWG) as its first diagnostic member. T2 Biosystems joins thirteen antimicrobials companies in their mission to combat drug resistant infections and spur life-saving innovations.  ...
Jul 18, 2017 08:00 am ET
T2 BIOSYSTEMS RECEIVES CE MARK FOR T2BACTERIA™ PANEL ENABLING COMMERCIALIZATION IN EUROPE
LEXINGTON, Mass., July 18, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development of innovative diagnostic products to improve patient health, announced today that it has received a CE Mark for its T2Bacteria Panel, allowing for the sale and distribution of the product within the European Union and those countries accepting the CE Mark. The T2Bacteria Panel runs on the Company’s proprietary T2Dx® Instrument and provides highly accurate species-specific test results of targeted bacterial infections direct from whole blood in as fast as about 3.5 ho...
Jun 07, 2017 08:00 am ET
T2 Biosystems Announces New T2Sepsis Solution™ Clinical and Economic Results Presented by Leading Experts at ASM Microbe 2017 Conference
Clinical Experts Discuss T2BacteriaTM Early Experience and Potential Emergency Department Applications...
May 02, 2017 04:01 pm ET
T2 Biosystems Reports First Quarter 2017 Results and Corporate Update
LEXINGTON, Mass., May 02, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced operating highlights and financial results for the first quarter ended March 31, 2017....
May 01, 2017 09:00 am ET
T2 Biosystems Names Darlene Deptula-Hicks as Chief Financial Officer
LEXINGTON, Mass., May 01, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that Darlene Deptula-Hicks has been named senior vice president and chief financial officer....
Apr 24, 2017 07:53 am ET
T2 Biosystems Announces 2017 First Quarter Financial and Operational Results Release and Conference Call Date
LEXINGTON, Mass., April 24, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2017 first quarter financial and operational results after the market closes on Tuesday, May 2, 2017. In conjunction with the release, the Company will host a conference call with the investment community at 4:30 p.m. Eastern Time on Tuesday, May 2, 2017, to discuss the financial results and other business developments....
Feb 13, 2017 04:01 pm ET
T2 Biosystems Reports Fourth Quarter and Full-Year 2016 Results
LEXINGTON, Mass., Feb. 13, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health and deliver a strong economic return to healthcare institutions, today announced operating highlights and financial results for the fourth quarter and year ended December 31, 2016....
Nov 03, 2016 04:01 pm ET
T2 Biosystems Announces New Data at IDWeek 2016
LEXINGTON, Mass., Nov. 03, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that the Company’s T2Candida® Panel for rapid sepsis detection and T2 Magnetic Resonance (T2MR®) technology for detecting early-stage Lyme disease were the focus of several poster presentations during IDWeek 2016. The meeting, hosted by the Infectious Diseases Society of America (IDSA) took place from October 26 – 30 in New Orleans, LA....
Nov 01, 2016 04:05 pm ET
T2 Biosystems Reports Third Quarter Results
Recent Collaborations and Strategic Investment Position Company for Long-Term Growth...
Nov 01, 2016 04:01 pm ET
T2 Biosystems Announces Collaboration with Allergan to Develop the First Blood-Based Diagnostic Panel to Detect Antimicrobial Resistance
-- T2 Biosystems to develop new panel on T2Dx platform and commercialize worldwide while receiving milestone and other payments –...
Oct 20, 2016 06:30 am ET
T2 Biosystems Announces 2016 Third Quarter and Nine-Month Results Release and Conference Call Date
LEXINGTON, Mass., Oct. 20, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 third quarter and nine-month financial results after the market closes on Tuesday, November 1, 2016.  In conjunction with the release, the Company will host a conference call with the investment community at 4:30 p.m. Eastern Time on Tuesday, November 1, 2016, to discuss the financial results and other business developments....
Oct 13, 2016 08:00 am ET
T2 Biosystems Announces Presentations at IDWeek 2016
LEXINGTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the Company’s T2 Magnetic Resonance (T2MR®) technology in detecting early-stage Lyme disease and T2Candida® Panel in rapid sepsis detection will be the focus of five poster presentations during IDWeek 2016. The conference, hosted by the Infectious Diseases Society of America, will take place October 26-30 in New Orleans....
Sep 22, 2016 08:00 am ET
T2 Biosystems Announces $40 Million Equity Investment by Partner Canon U.S.A.
LEXINGTON, Mass., Sept. 22, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the purchase by Canon U.S.A., of approximately $40 million of the company’s stock in a private placement. The shares were purchased at $6.56, the closing market price of Tuesday, September 20, 2016. With this investment, Canon owns 19.9 percent of T2 Biosystems and Canon’s chief administrative officer and general counsel, Seymour Liebman has joined the company’s board of directors. This private placement close...
Sep 21, 2016 04:01 pm ET
T2 Biosystems Presents Data on the Company’s T2MR® Technology for the Detection of the Bacteria that Causes Lyme Disease Directly from Whole Blood at Cold Spring Harbor Laboratory Conference on Diagn
LEXINGTON, Mass., Sept. 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, announced that Tom Lowery, Ph.D., chief scientific officer, today presented data on the T2 Magnetic Resonance (T2MR®) technology for the detection of Borrelia – the bacteria that causes Lyme disease – directly from whole blood samples. The data were presented at the Diagnostic Tests for Lyme Disease Conference at the Banbury Center at Cold Spring Harbor Laboratory in New York....
Aug 04, 2016 06:30 am ET
T2 Biosystems to Present at the Canaccord Genuity Growth Conference
LEXINGTON, Mass., Aug. 04, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Shawn Lynch, chief financial officer, are scheduled to attend and present at the Canaccord Genuity Growth Conference on Thursday, August 11, 2016, at 8:30 a.m. ET in Boston....
Aug 01, 2016 04:00 pm ET
T2 Biosystems Reports 2016 Second Quarter, Six-Month Results
LEXINGTON, Mass., Aug. 01, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today reported operating highlights and financial results for the second quarter and six months ended June 30, 2016.  Recent operational highlights included:...
Jul 21, 2016 06:30 am ET
T2 Biosystems Announces 2016 Second Quarter and Six-Month Results Release and Conference Call Date
LEXINGTON, Mass., July 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that it will release its 2016 second quarter and six-month financial results after the market closes on Monday, August 1, 2016.  In conjunction with the release, the Company will host a conference call with the investment community at 4:30 p.m. Eastern Time on Monday, August 1, 2016, to discuss the financial results and other business developments....
Jul 18, 2016 08:00 am ET
T2 Biosystems Announces Research and Development Collaboration with Bayer to Advance Drug Monitoring and Biomarker Discovery for Blood Coagulation Disorders
LEXINGTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, has signed a multi-year agreement to provide T2 Biosystems’ T2 Magnetic Resonance technology platform, or T2MR®, for Bayer’s research and development efforts in blood coagulation disorders. This collaboration will develop tools and evaluate assays to help drive drug discovery and biomarker research for select Bayer hemostasis-related programs....
Jul 13, 2016 01:00 am ET
Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer
CAMBRIDGE, Mass., July 13, 2016 /PRNewswire/ -- Flagship Ventures today announced the appointment of industry veteran Michael Rosenblatt, M.D., to the new position of Chief Medical Officer. In this capacity, Dr. Rosenblatt will lead global clinical development and medical affairs for the organization.  He will play a key role in Flagship's internal venture creation team during the conception and launch of the next generation of pioneering biotechnology companies as well as serve as an ongoing strategic resource for all companies in the Flagship ecosystem supporting their clinical development...
Jul 07, 2016 04:01 pm ET
T2 Biosystems Announces Preliminary Second Quarter Commercial, Clinical and Executive Personnel Updates
LEXINGTON, Mass., July 07, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced preliminary commercial metrics for its second quarter, news regarding replacement of products at customer sites, an update on the timing for completing clinical trials for the T2Bacteria® Panel, news from the recent ASM Microbe 2016 conference and the planned appointment of a veteran operations executive to the position of chief operations officer (COO)....
Jul 05, 2016 06:30 am ET
T2 Biosystems to Present at the Cantor Fitzgerald Healthcare Conference
LEXINGTON, Mass., July 05, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Shawn Lynch, chief financial officer, are scheduled to attend and present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on Tuesday, July 12, 2016, at 11:15 a.m. ET in New York City....
Jun 29, 2016 05:47 pm ET
Flagship Ventures Names Daniel McIntyre Partner
CAMBRIDGE, Mass., June 29, 2016 /PRNewswire/ -- Flagship Ventures today announced the appointment of Daniel McIntyre to the position of Partner, Strategic Communication.  In this new role, he is responsible for communication for Flagship's growing organization as well as for its expanding ecosystem of internally generated start-up companies....
Jun 21, 2016 04:01 pm ET
T2 Biosystems Announces New Data at ASM Microbe 2016 Demonstrating Benefits of Adopting T2Candida® Panel for Diagnosing Sepsis in Clinical Settings
LEXINGTON, Mass., June 21, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida® Panel was the focus of one slide session and three poster presentations during ASM Microbe 2016, integrating the American Society of Microbiology’s two premier events, the General Meeting and the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The annual meeting took place June 16-20 in Boston. Data from these third-party studies demonstrate the T2Candida Panel’s ability t...
Jun 08, 2016 06:30 am ET
T2 Biosystems Announces Presentations at ASM Microbe 2016
LEXINGTON, Mass., June 08, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced the T2Candida® Panel will be the focus of a company symposium, one slide session and three poster presentations during ASM Microbe 2016, integrating the American Society of Microbiology’s two premier events, the General Meeting and the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). The annual meeting will take place June 16-20 in Boston....
Jun 02, 2016 08:09 am ET
Study Published in the American Journal of Clinical Pathology Demonstrates T2Candida Panel Provides Rapid and Accurate Diagnosis of Candida, a Leading Cause of Sepsis, in Pediatric Patients
LEXINGTON, Mass., June 02, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that results from an investigational study evaluating its T2Candida® Panel utilizing two mL of whole blood in pediatric patients was published in the American Journal of Clinical Pathology (AJCP). The data demonstrate that in each of the 15 confirmed pediatric candidemia samples in the study, the T2Candida Panel was able to accurately identify the Candida species in three to five hours compared to up to six d...
May 02, 2016 04:05 pm ET
T2 Biosystems to Transition Chief Financial Officer Role to Shawn Lynch
LEXINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today announced that Chief Financial Officer (CFO) Moe Castonguay has decided to retire and that senior financial executive, Shawn Lynch, will be named CFO, effective May 16.  ...
May 02, 2016 04:00 pm ET
T2 Biosystems Reports 2016 First Quarter Results
LEXINGTON, Mass., May 02, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a company developing innovative diagnostic products to improve patient health, today reported operating highlights and financial results for the first quarter ended March 31, 2016.  Recent operational highlights included:...
Apr 27, 2016 06:30 am ET
T2 Biosystems to Present at Deutsche Bank Health Care Conference
LEXINGTON, Mass., April 27, 2016 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) today announced that John McDonough, president and chief executive officer, and Moe Castonguay, chief financial officer, are scheduled to attend and present at the Deutsche Bank 41st Annual Health Care Conference on Wednesday, May 4, 2016, at 2:10 p.m. ET in Boston....

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.